SHADEFAI GOLDSMITH: Open Payments
NPI 1760622807 · ROCHESTER, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$507 in 7 payments from 3 companies in 2025. Trend: 2023 $456 · 2024 $743 · 2025 $507
Food & beverage: $507
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 5 | $283 |
| GlaxoSmithKline, LLC. | 1 | $121 |
| ABBVIE INC. | 1 | $103 |
Products named: OTEZLA, BENLYSTA, TAVNEOS, SKYRIZI, ENBREL.
Industry payments across NY — which companies pay providers there.
